BAYZF
Price
$30.92
Change
-$0.28 (-0.90%)
Updated
Jul 3 closing price
Capitalization
57.55B
CMOPF
Price
$64.37
Change
+$9.37 (+17.04%)
Updated
May 28 closing price
Capitalization
827.91M
Interact to see
Advertisement

BAYZF vs CMOPF

Header iconBAYZF vs CMOPF Comparison
Open Charts BAYZF vs CMOPFBanner chart's image
Bayer A.G
Price$30.92
Change-$0.28 (-0.90%)
Volume$302
Capitalization57.55B
Cosmo Pharmaceuticals
Price$64.37
Change+$9.37 (+17.04%)
Volume$200
Capitalization827.91M
BAYZF vs CMOPF Comparison Chart in %
Loading...
BAYZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMOPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAYZF vs. CMOPF commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAYZF is a Hold and CMOPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (BAYZF: $30.92 vs. CMOPF: $64.37)
Brand notoriety: BAYZF and CMOPF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BAYZF: 9% vs. CMOPF: 100%
Market capitalization -- BAYZF: $57.55B vs. CMOPF: $827.91M
BAYZF [@Pharmaceuticals: Major] is valued at $57.55B. CMOPF’s [@Pharmaceuticals: Major] market capitalization is $827.91M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAYZF’s FA Score shows that 0 FA rating(s) are green whileCMOPF’s FA Score has 1 green FA rating(s).

  • BAYZF’s FA Score: 0 green, 5 red.
  • CMOPF’s FA Score: 1 green, 4 red.
According to our system of comparison, CMOPF is a better buy in the long-term than BAYZF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAYZF’s TA Score shows that 3 TA indicator(s) are bullish while CMOPF’s TA Score has 4 bullish TA indicator(s).

  • BAYZF’s TA Score: 3 bullish, 5 bearish.
  • CMOPF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, CMOPF is a better buy in the short-term than BAYZF.

Price Growth

BAYZF (@Pharmaceuticals: Major) experienced а +0.89% price change this week, while CMOPF (@Pharmaceuticals: Major) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.19%. For the same industry, the average monthly price growth was +2.56%, and the average quarterly price growth was +9.33%.

Industries' Descriptions

@Pharmaceuticals: Major (+1.19% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAYZF($57.5B) has a higher market cap than CMOPF($828M). CMOPF has higher P/E ratio than BAYZF: CMOPF (68.49) vs BAYZF (17.12). BAYZF YTD gains are higher at: 56.359 vs. CMOPF (-3.818). BAYZF has higher annual earnings (EBITDA): 12.1B vs. CMOPF (42.1M). BAYZF has more cash in the bank: 7.98B vs. CMOPF (222M). CMOPF has less debt than BAYZF: CMOPF (176M) vs BAYZF (41.3B). BAYZF has higher revenues than CMOPF: BAYZF (50.5B) vs CMOPF (104M).
BAYZFCMOPFBAYZF / CMOPF
Capitalization57.5B828M6,944%
EBITDA12.1B42.1M28,741%
Gain YTD56.359-3.818-1,476%
P/E Ratio17.1268.4925%
Revenue50.5B104M48,558%
Total Cash7.98B222M3,592%
Total Debt41.3B176M23,466%
FUNDAMENTALS RATINGS
BAYZF vs CMOPF: Fundamental Ratings
BAYZF
CMOPF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
15
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9389
PRICE GROWTH RATING
1..100
4061
P/E GROWTH RATING
1..100
8997
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMOPF's Valuation (15) in the null industry is somewhat better than the same rating for BAYZF (70). This means that CMOPF’s stock grew somewhat faster than BAYZF’s over the last 12 months.

CMOPF's Profit vs Risk Rating (100) in the null industry is in the same range as BAYZF (100). This means that CMOPF’s stock grew similarly to BAYZF’s over the last 12 months.

CMOPF's SMR Rating (89) in the null industry is in the same range as BAYZF (93). This means that CMOPF’s stock grew similarly to BAYZF’s over the last 12 months.

BAYZF's Price Growth Rating (40) in the null industry is in the same range as CMOPF (61). This means that BAYZF’s stock grew similarly to CMOPF’s over the last 12 months.

BAYZF's P/E Growth Rating (89) in the null industry is in the same range as CMOPF (97). This means that BAYZF’s stock grew similarly to CMOPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAYZFCMOPF
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 6 days ago
38%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
60%
Bullish Trend 3 days ago
20%
Momentum
ODDS (%)
Bearish Trend 3 days ago
67%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
6%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
23%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
23%
Advances
ODDS (%)
Bullish Trend 4 days ago
62%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
71%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
25%
View a ticker or compare two or three
Interact to see
Advertisement
BAYZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CMOPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLRRX12.230.15
+1.24%
NYLI Winslow Large Cap Growth Class R1
JIISX82.190.70
+0.86%
JPMorgan US Sustainable Leaders I
PORIX60.580.36
+0.60%
Trillium ESG Global Equity Institutional
FIJDX38.850.22
+0.57%
Fidelity Advisor Gold Z
UEIPX14.470.06
+0.42%
UBS Engage For Impact P

BAYZF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAYZF has been closely correlated with BAYRY. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAYZF jumps, then BAYRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAYZF
1D Price
Change %
BAYZF100%
-0.90%
BAYRY - BAYZF
88%
Closely correlated
-1.16%
CSPCY - BAYZF
13%
Poorly correlated
+4.50%
GIFLF - BAYZF
10%
Poorly correlated
N/A
CHGCY - BAYZF
6%
Poorly correlated
-0.89%
GIFOF - BAYZF
6%
Poorly correlated
N/A
More

CMOPF and

Correlation & Price change

A.I.dvisor tells us that CMOPF and CHGCF have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CMOPF and CHGCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMOPF
1D Price
Change %
CMOPF100%
N/A
CHGCF - CMOPF
10%
Poorly correlated
-9.99%
CHGCY - CMOPF
5%
Poorly correlated
-0.89%
BAYZF - CMOPF
2%
Poorly correlated
-0.90%
GIFLF - CMOPF
1%
Poorly correlated
N/A
CHJTF - CMOPF
-0%
Poorly correlated
N/A
More